-
摘要: 目的 研究CD18在脓毒症肠损伤中的作用及机制。方法 将36只小鼠随机分为对照组、脓毒症组、抗CD18组, 腹腔注射LPS建立脓毒症小鼠模型; 抗CD18组先尾静脉注射CD18抗体, 30 min后腹腔注射LPS; 造模24 h后检测血清中β2整合素、D-乳酸、肝素结合蛋白(HBP)、肿瘤坏死因子-α(TNF-α)水平; 检测小肠组织中炎症因子(IL-6、IL-10)、紧密连接蛋白(ZO-1、Claudin-1)、Rho信号通路蛋白(ROCK1、mDia1)的表达水平及RhoA活性; 采用苏木精-伊红染色评估小肠病理损伤, 透射电镜观察小肠组织超微结构改变。结果 ① CD18抗体提高了脓毒症小鼠24 h存活率。②CD18抗体减轻了脓毒症小鼠小肠损伤(小肠病理损伤减轻、上皮间紧密连接破坏减轻、紧密连接蛋白表达增多), 改善了肠道通透性(D-乳酸水平下降)。③CD18抗体抑制了Rho信号通路(RhoA活性下降、ROCK1和mDia1表达减少)。结论 抑制CD18可以减轻脓毒症肠损伤, 改善肠道通透性; CD18可能是通过Rho信号通路参与了脓毒症的肠损伤。Abstract: Objective To study the role and mechanism of CD18 in sepsis intestinal injury.Methods Thirty-six mice were randomly divided into control group, sepsis group and anti-CD18 group, and the sepsis mouse model was established by intraperitoneal injection of LPS.In the anti-CD18 group, CD18 antibody was injected into caudal vein at first, and LPS was injected intraperitoneally 30 min later.The serum levels of β2 integrin, HBP, D-lactate and TNF-α were detected 24 hours after modeling.Meanwhile, RhoA activity and the expression levels of inflammatory factors (IL-6, IL-10), tight junction proteins (ZO-1, Claudin-1), Rho signaling pathway proteins (ROCK1, mDia1) in small intestine were also detected.HE staining was used to evaluate the pathological damage of small intestine, and the ultrastructural changes of small intestine were observed by transmission electron microscopy.Results ① Anti-CD18 treatment increased the survival rate of sepsis mice for 24 h.②Anti-CD18 treatment attenuated intestinal pathological injury in sepsis mice, repaired tight junctions between epithelial cells (increase of tight junction proteins), and improved intestinal permeability (decrease of D-lactate level).③Anti-CD18 treatment inhibited the Rho signaling pathway (decrease of RhoA activity, decrease of ROCK1 and mDia1 expression).Conclusion Inhibition of CD18 can alleviate intestinal damage and improve intestinal permeability in sepsis.CD18 may be involved in intestinal damage in sepsis through the Rho signaling pathway.
-
Key words:
- CD18 /
- sepsis /
- intestinal permeability /
- tight junction protein /
- Rho signaling pathwa
-
[1] 黄昆鹏, 张进祥. 脓毒症的定义、诊断与早期干预——不可分割的三要素[J]. 临床急诊杂志, 2021, 22(3): 221-226. https://www.cnki.com.cn/Article/CJFDTOTAL-ZZLC202103016.htm
[2] Chen P, Billiar T. Gut microbiota and multiple organ dysfunction syndrome(MODS)[J]. Adv Exp Med Biol, 2020, 1238: 195-202.
[3] Bednarczyk M, Stege H, Grabbe S, et al. β2 integrins-multi-functional leukocyte receptors in health and disease[J]. Int J Mol Sci, 2020, 21(4): 1402. doi: 10.3390/ijms21041402
[4] 刘杨, 马少林, 王学斌, 等. 整合素介导的肝素结合蛋白在肺损伤模型中的作用[J]. 中华急诊医学杂志, 2018, 27(7): 764-768. doi: 10.3760/cma.j.issn.1671-0282.2018.07.011
[5] Liu Y, Ma SL, Wang XB, et al. The role of β2 integrin associated heparin-binding protein release in ARDS[J]. Life Sci, 2018, 203: 92-98. doi: 10.1016/j.lfs.2018.04.029
[6] Wang BM, Lim JH, Kajikawa T, et al. Macrophage β2-integrins regulate IL-22 by ILC3 s and protect from lethal Citrobacter rodentium-induced colitis[J]. Cell Rep, 2019, 26(6): 1614-1626. e5. doi: 10.1016/j.celrep.2019.01.054
[7] 雷泓, 顾莹, 陈军仿, 等. Stattic对脂多糖诱导的肠道屏障功能障碍小鼠小肠组织基质金属蛋白酶-9表达的影响[J]. 中华实用诊断与治疗杂志, 2021, 35(10): 997-1000. https://www.cnki.com.cn/Article/CJFDTOTAL-HNZD202110008.htm
[8] Longhitano Y, Zanza C, Thangathurai D, et al. Gut alterations in septic patients: a biochemical literature review[J]. Rev Recent Clin Trials, 2020, 15(4): 289-297. doi: 10.2174/18761038MTA5BMDIr2
[9] Schoultz I, Keita ÅV. The intestinal barrier and current techniques for the assessment of gut permeability[J]. Cells, 2020, 9(8): 1909. doi: 10.3390/cells9081909
[10] Usuda H, Okamoto T, Wada K. Leaky gut: effect of dietary fiber and fats on microbiome and intestinal barrier[J]. Int J Mol Sci, 2021, 22(14): 7613.
[11] He CM, Deng J, Hu X, et al. Vitamin A inhibits the action of LPS on the intestinal epithelial barrier function and tight junction proteins[J]. Food Funct, 2019, 10(2): 1235-1242. doi: 10.1039/C8FO01123K
[12] Rohr MW, Narasimhulu CA, Rudeski-Rohr TA, et al. Negative effects of a high-fat diet on intestinal permeability: a review[J]. Adv Nutr, 2020, 11(1): 77-91. doi: 10.1093/advances/nmz061
[13] Zhang Q, Gao X, Wu JX, et al. The correlation between endotoxin, D-lactate, and diamine oxidase with endoscopic activity in inflammatory bowel disease[J]. Dis Markers, 2022, 2022: 9171436. http://doc.paperpass.com/foreign/rgPrep2020388444266.html
[14] Zhang SF, Zhou QN, Li YC, et al. MitoQ modulates lipopolysaccharide-induced intestinal barrier dysfunction via regulating Nrf2 signaling[J]. Mediators Inflamm, 2020, 2020: 3276148.
[15] 李荔, 冯贵龙, 牛争平. 肝素结合蛋白分子特性及其与感染性疾病关系研究进展[J]. 中华实用诊断与治疗杂志, 2022, 36(4): 418-421. https://www.cnki.com.cn/Article/CJFDTOTAL-HNZD202204023.htm
[16] Wu YL, Yo CH, Hsu WT, et al. Accuracy of heparin-binding protein in diagnosing sepsis: a systematic review and meta-analysis[J]. Crit Care Med, 2021, 49(1): e80-e90.
[17] Liu ZX, Chen MM, Sun YN, et al. Transforming growth factor-β receptor type 2 is required for heparin-binding protein-induced acute lung injury and vascular leakage for transforming growth factor-β/Smad/Rho signaling pathway activation[J]. FASEB J, 2022, 36(11): e22580.
[18] Pajenda S, Figurek A, Wagner L, et al. Heparin-binding protein as a novel biomarker for sepsis-related acute kidney injury[J]. PeerJ, 2020, 8: e10122.
[19] Sun JK, Shen X, Sun XP, et al. Heparin-binding protein as a biomarker of gastrointestinal dysfunction in critically ill patients: a retrospective cross-sectional study in China[J]. BMJ Open, 2020, 10(7): e036396.
[20] 郭娜, 宁海慧, 邢博民, 等. Rho/ROCK信号通路在脓毒症相关脏器损伤中的作用及机制研究进展[J]. 临床急诊杂志, 2021, 22(7): 503-507. https://www.cnki.com.cn/Article/CJFDTOTAL-ZZLC202107015.htm
[21] Ryu H, Lee HN, Ju J, et al. Combinatorial effects of RhoA and Cdc42 on the actin cytoskeleton revealed by photoswitchable GEFs[J]. Sens Actuat B Chem, 2022, 369: 132316.
[22] Jin Y, Blikslager AT. The regulation of intestinal mucosal barrier by myosin light chain kinase/rho kinases[J]. Int J Mol Sci, 2020, 21(10): 3550.
[23] Hahmeyer MLDS, da Silva-Santos JE. Rho-proteins and downstream pathways as potential targets in Sepsis and septic shock: what have we learned from basic research[J]. Cells, 2021, 10(8): 1844.
[24] Li ZL, Gao M, Yang BC, et al. Naringin attenuates MLC phosphorylation and NF-κB activation to protect sepsis-induced intestinal injury via RhoA/ROCK pathway[J]. Biomed Pharmacother, 2018, 103: 50-58.
[25] Yang T, Wang L, Sun RQ, et al. Hydrogen-rich medium ameliorates lipopolysaccharide-induced barrier dysfunction via rhoa-mdia1 signaling in caco-2 cells[J]. Shock, 2016, 45(2): 228-237.